Measure 109 [would allow] therapy using the active ingredient in hallucinogenic mushrooms
The measure does set up a two-year development period that will cost a small sum [the financial impact during the two-year development period, which runs through December of 2022, is estimated to be $7.0 million General Fund to begin activities required under the Act according to the Department of Administrative Services] before the system of taxing the drug is established.
The measure does not decriminalize psilocybin, a schedule 1 drug under federal rules and thus not approved for any medical uses… many professionals have come out against it. The measure does set up a screening system so people suffering from disorders like schizophrenia, would not be allowed take psilocybin… it does not allow people to buy psilocybin and take it home. It will not be legal to consume psilocybin without guidance or oversight.
Original Article (OPB):
Measure 109 will allow therapy using the active ingredient in hallucinogenic mushrooms
Artwork Fair Use: Jason McHuff